FDA approves cervical disk device

July 17, 2007

The U.S. Food and Drug Administration Tuesday announced approval of the first device designed to treat cervical degenerative disc disease.

The Prestige Cervical Disc, manufactured by Medtronic Sofamor Danek of Memphis, is used to treat one of the most common causes of neck and arm pain.

"The approval of this artificial disc means that people with cervical degenerative disc disease now will have another surgical option for treating this condition," said Dr. Daniel Schultz, director of the FDA's Center for Devices and Radiological Health. "This device will help relieve pain and restore function."

The FDA said current surgical treatments involve removing a diseased or bulging disc in a patient's neck and fusing two or more bony vertebrae. The Prestige Cervical Disc allows the option of replacing the impaired natural disc.

The FDA said it based its approval on the company's laboratory and animal testing, and on its clinical study of 541 patients.

As a condition of approval, the company will conduct a post-approval study during the next seven years to evaluate the longer term safety and effectiveness of the device.

The Prestige Cervical Disc was approved as a class III, or high-risk, device.

Copyright 2007 by United Press International

Related Stories

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.